biotherapeutics
| 2 min read
The state-of-the-art facility will deliver CGMP plasmid DNA development and manufacturing services by late 2025.
Available on Demand
Cell-free gene synthesis removes key bottlenecks in mRNA synthesis, accelerating the development of lifesaving therapies.
| 1 min read
Bacterial contaminants in cell cultures pose a significant threat to the biopharmaceutical safety. How do scientists detect these hard-to-spot pests?
Page 1 of 1 - 3 Total Items
